Nicotinamide + pyridoxine

Nicotinamide + pyridoxine has been studied in 4 papers since 2024: 1 trial in people, 1 in animals, 1 review; 1 in the past year. The newest paper, Mar 24, 2026: “Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men”.

Intervention

4 papers study it11 findingsUpdated

See all 4 papers on nicotinamide + pyridoxine

At a glance

The findings reach people, from one lab or study. 3 independent labs in 3 countries.

“the number of Pax7, MyoD, and myogenin positive cells per damaged fiber was significantly higher in NAM/PN vs placebo groups (+29%-67%).”
Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young MenAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026doi:10.1002/advs.202518471

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 3 independent labs in 3 countries
  • Funders: Nestle Health Science and others
  • 8 of 10 findings with company ties
  • Human trial1
  • Animals1

Studies in people

1 study gave nicotinamide + pyridoxine to people and measured what changed.

What changedDesignPeopleSource

up: Increases MuSC activity+29%

up: Increases MyoD+ cells+67%

up: Increases myogenin+ cells34%

Randomized trial9 days43 peoplemalesmean age of 26.7 yearsHealthy males aged 18 to 49 yearsAdvanced science (Weinheim, Baden-Wurttemberg, Germany), Mar 24, 2026

What did studies of nicotinamide + pyridoxine find?

10

Studies of nicotinamide + pyridoxine measured 10 outcomes, among them muscle regeneration, muscle regeneration and Myogenin+ cells.

Muscle regeneration

upin humans1upin M. organisms1+37%

2 studies
  1. Nicotinamide + pyridoxine increases muscle regeneration in humans following damaging unilateral eccentric muscle contractions (+37%).

    “NAM/PN also increased the proportion of regenerating fibers (+37%).”

    Human trialfollowing damaging unilateral eccentric muscle contractionsvastus lateralis muscle714 mg NAM and 19 mg PN daily9 daysmalesn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  2. Nicotinamide + pyridoxine increases muscle regeneration in M. organisms.

    “Oral treatment with a combination of NAM and PN accelerated muscle regeneration in vivo by stimulating MuSCs”

    Animalsskeletal muscle

    Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging

    The Journal of clinical investigation

muscle regeneration

upin humans1+37%

1 study
  1. Nicotinamide + pyridoxine increases muscle regeneration in humans (+37%).

    “Importantly, the percentage of damaged fibers expressing eMyHC+ at Day 8 was significantly higher in the NAM/PN group compared to placebo (Figure; +37%; p = 0.04), indicating that NAM/PN supplementation accelerates the differentiation of MuSCs into eMyHC+ regenerating fibers.”

    Human trial9 daysn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Myogenin+ cells

upin humans1+34%

1 study
  1. Nicotinamide + pyridoxine increases myogenin+ cells in humans (34%).

    “The supplementation of NAM/PN also significantly enhanced more terminal markers of myogenic differentiation as the number of myogenin+ cells was also significantly elevated in NAM/PN vs placebo compared to the placebo group (Figure; 34%; p = 0.029).”

    Human trial9 daysn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

MyoD+ cells

upin humans1+67%

1 study
  1. Nicotinamide + pyridoxine increases MyoD+ cells in humans (+67%).

    “Consistently, the number of MyoD+ cells representing differentiating MuSCs was very robustly increased following NAM/PN vs placebo supplementation (Figure; +67%; p = 0.0002).”

    Human trial9 daysn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on MyoD+ cells

MuSC activity

upin humans1+29%

1 study
  1. Nicotinamide + pyridoxine increases MuSC activity in humans (+29%).

    “The supplementation of NAM/PN significantly increased the number of activated Pax7+ cells (Figure; +29%; p = 0.03 vs placebo), while the number of quiescent Pax7+ cells was not affected by the treatment.”

    Human trial9 daysn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on MuSC activity

MuSC activity

upin humans1

1 study
  1. Nicotinamide + pyridoxine increases muSC activity in humans following damaging unilateral eccentric muscle contractions (+29%-67%).

    “the number of Pax7, MyoD, and myogenin positive cells per damaged fiber was significantly higher in NAM/PN vs placebo groups (+29%-67%).”

    Human trialfollowing damaging unilateral eccentric muscle contractionsvastus lateralis muscle714 mg NAM and 19 mg PN daily9 daysmalesn = 39

    Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Short-term adverse effects

no changein humans1

1 study
  1. Nicotinamide + pyridoxine was not clearly linked with short-term adverse effects in humans (KYNU deficiency, treated from young age).

    “which improved biochemistry without evident short-term adverse effects”

    HumansKYNU deficiency, treated from young agen = 2

    Two new cases of KYNU deficiency: Further delineation of the phenotypic and biochemical spectrum and exploration of treatment options

    Molecular genetics and metabolism

Biochemistry

upin humans1

1 study
  1. Nicotinamide + pyridoxine is linked with better biochemistry in humans (KYNU deficiency, treated from young age).

    “which improved biochemistry without evident short-term adverse effects”

    HumansKYNU deficiency, treated from young agen = 2

    Two new cases of KYNU deficiency: Further delineation of the phenotypic and biochemical spectrum and exploration of treatment options

    Molecular genetics and metabolism

More on Biochemistry

Muscle stem cell function

upin mice1

1 study
  1. Nicotinamide + pyridoxine improves muscle stem cell function in mice.

    “The combination of the two compounds promoted MuSC function in vivo in aged mice”

    Reviewskeletal muscle

    The muscle stem cell case of Benjamin Button: rejuvenating muscle regenerative capacity through nutraceuticals

    The Journal of clinical investigation

Muscle strength

upin M. organisms1

1 study
  1. Nicotinamide + pyridoxine increases muscle strength in M. organisms during recovery.

    “increased muscle strength during recovery”

    Animalsduring recovery

    Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging

    The Journal of clinical investigation

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months